Skip to content

RVMD

Revolution Medicines, Inc.

NASDAQ · Healthcare · Biotechnology · US

$190.90
−3.07%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
61.66x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
15.70x
Price / sales
Price / cash flow
-25.94x

Enterprise value

Enterprise value
$37.6B
EV / sales
EV / EBITDA
-22.19x
EV / EBIT
-23.12x
Market cap
$40.9B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026